MOBI
Mobia Medical, Inc.
NasdaqGS Healthcare United States
9,59 $US
+4.47% today
-18.38% YTD · -18.38% 1Y
7
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
2
Hedge funds tracked
Latest available SEC 13F filings
56
/ 100
MIXED

Analysis Mobia Medical, Inc. (MOBI) — Kairos Score 56/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Mobia Medical, Inc.

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Key info

👔
CEO
Mr. Richard John Foust
📍
HQ
2802 Flintrock Trace, Suite 226, Austin, TX, 78738, United States
👥
Employees
167
💰
Market cap
319 261 660,00 $US
💸
Dividend yield
—

🕴️ Insider activity (90 days)

7 transactions — 6 buys and 0 sales reported by Mobia Medical, Inc. executives.

LC
Leavitt Chase C.
SEE REMARKS · 2026-09-11
Buy
RP
Rawat Prashant B.
Chief Operating Officer · 2026-09-02
Other
TC
Tansey Casey M
2026-08-18
Buy

🏦 Hedge Funds

2 institutional funds report a position on MOBI in their latest SEC quarterly filing.

GEODE CAPITAL MANAGEMENT, LLC
MARSHALL WACE, LLP

📰 Recent news

11 recent articles on MOBI.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Mobia Medical, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of MOBI on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 7 insider transactions over 90 days
✅ All 2 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year